Centene Corporation Reports Positive 2024 Medicare Advantage Star Ratings

Centene Corporation, a healthcare company operating in the United States, has filed a Form 8-K report with the U.S. Securities and Exchange Commission disclosing the company's performance in the 2024 Medicare Advantage Star Ratings issued by the Centers for Medicare and Medicaid Services. According to the report, Centene's analysis of the newly released data indicates that approximately 73% of its membership is associated with contracts showing year-over-year unrounded score improvement, and approximately 87% of its membership is associated with contracts rated 3.0 stars or better.

Key Takeaways:

  • Centene's 2024 Medicare Advantage Star Ratings show a significant improvement compared to the prior year, with 73% of membership associated with contracts showing year-over-year unrounded score improvement.
  • Approximately 87% of Centene's membership is associated with contracts rated 3.0 stars or better, up from 53% in the prior year.
  • These results are in line with the company's recent public commentary regarding expectations of approximately two-thirds of members showing raw score improvement and roughly 90% of members in contracts crossing the three-star threshold.
  • While the company still has work to do to improve star scores, this shows the first step towards its multi-year goals.
  • The company has filed a Form 8-K report with the U.S. Securities and Exchange Commission disclosing its performance in the 2024 Medicare Advantage Star Ratings.

Statistics:

  • 73% of Centene's membership is associated with contracts showing year-over-year unrounded score improvement.
  • Approximately 87% of Centene's membership is associated with contracts rated 3.0 stars or better.
  • This is compared to 53% in the prior year.

Sources:

  • U.S. Securities and Exchange Commission (Form 8-K, October 16, 2023)
  • Improvements in the Medicare Star Ratings demonstrate the company's efforts to provide value-based care to its members.
  • The company's continued focus on quality care and improvement in star ratings positions it for long-term success in the healthcare industry.